BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Hybrigenics SA 

180 Avenue Daumesnil

Paris    F-75012  France
Phone: 33-1-70-91-29-00 Fax: 33-1-70-91-29-49


SEARCH JOBS


Industry
Biotechnology






 Company News
Hybrigenics Starts Phase II Clinical Trial of Inecalcitol in Chronic Lymphocytic Leukemia 9/11/2012 11:00:28 AM    More...
Bryan, Garnier & Co Initiates Coverage of Hybrigenics with a Target Price of €2.6 3/29/2012 6:56:24 AM    More...
Hybrigenics' Specific Inhibitor of Ubiquitin-Specific Protease 7 (USP7) is Cytotoxic for Chronic Lymphocytic Leukaemia (CLL) Cells in Vitro 10/28/2011 10:33:53 AM    More...
Hybrigenics 2011 First-Half Results 10/18/2011 11:02:59 AM    More...
Hybrigenics and Servier Enter into a License and Research Collaboration Agreement in Oncology and Other Therapeutic Fields 10/10/2011 9:49:14 AM    More...
Hybrigenics Appoints Dr Alain Munoz to its Board of Directors 10/5/2011 10:55:57 AM    More...
Hybrigenics Gets Approval and Funding for a Phase II Clinical Trial of Inecalcitol in Psoriasis 9/6/2011 11:27:12 AM    More...
Hybrigenics Maintains Stable EUR Two Million Revenues in First Half of 2011 8/23/2011 10:00:15 AM    More...
Hybrigenics' Inecalcitol Inhibits the Growth of Human Hormone-Dependent Prostate Cancer Cells in Vitro and in Vivo 7/12/2011 9:23:23 AM    More...
Hybrigenics to Present Inecalcitol Results at the Annual Meeting of the American Society of Clinical Oncology 6/1/2011 8:46:52 AM    More...
123456

//-->